|Articles|November 30, 2011
Podcast - SAFC Grant E. Boldt
John Kelly, vice-president of strategy and transitioning sites for Pfizer Global Supply, discusses the company's manufacturing and supply strategy and network.
Advertisement
Grant E. Boldt, PhD
director of European business development,
SAFC
Grant E. Boldt, PhD, director of European business development for SAFC, discusses manufacturing considerations in producing antibody drug conjugates with Patricia Van Arnum, executive editor, of Pharmaceutical Technology.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development
2
AI and Human Collaboration Essential for Bio/pharma Innovation
3
Sustainability and Stability in Excipients
4
Centralizing AI Strategy, Ensuring Process Integrity, and Balancing Quick Wins with Long-Term Drug Design in Bio/pharma
5
